VEO DIAGNOSTICS, LLC recalls ACCEL ELISA COVID-19 for the detection of total antibodies to SARS-CoV-2 Catalog AE301U Kit lots: PXCOV073020, PXCOV081…
- Recall date
- November 5, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0510-2021
- FDA classification
- Class II
- Brand / firm
- VEO DIAGNOSTICS, LLC
- Sold / distributed
- US Nationwide distribution including in the states of IA, PA, WA.
Why it was recalled
Emergency Use Authorization (EUA) removed from list of COVID-19 antibody tests
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
ACCEL ELISA COVID-19 for the detection of total antibodies to SARS-CoV-2 Catalog AE301U Kit lots: PXCOV073020, PXCOV081220 Expiration dates: January 18, 2021 and January 26, 2021
Get recall alerts
Free email alert whenever VEO DIAGNOSTICS, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: VEO DIAGNOSTICS, LLC